Cell line TriH8 obtained by the fusion of the human epidermoid carcinoma cell line A431 with the TOS/H8 hybridoma

摘要

A new cell line TriH8 is obtained by fusing a particular sub- clone, A431c, of the human epidermoid carcinoma cell line A431 with the TOS/H8 (human/human) hybridoma. Fused cell TriH8 has been deposited under FRI accession number FERM BP-4452. The fused cell is capable of proliferating in basal medium without addition of serum or growth factor. The cell line is more effective in producing antibody (IgM) than the donor cell TOS/H8.